Hellenic Cooperative Oncology Group

Biotech

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Oct 29, 2026

Recruiting

Whole Exome and Transcriptome Sequencing Analysis for the Identification of Prognostic Biomarkers in Patients With Non-Small Cell Lung Cancer (NSCLC) - Hellenic Cooperative Oncology Group (HeCOG)

Oct 28, 2026

Recruiting

Recording ESR1 Mutations in Metastatic Hormone Receptor-Positive Breast Cancer in the Greek Population: A Non-Interventional, Retrospective and Prospective Observational Study of Clinical Practice Data and Treatment Utilization Patterns in Routine Care

Oct 23, 2026

Recruiting

Folate Receptor Alpha (FRα) Expression and Heterogeneity in Epithelial Ovarian Cancer

Earlier

Oct 20, 2026TrialReal World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer

Oct 20, 2026TrialMelanoma: Genomic Profiles, Molecular Markers and Therapeutic Implications

Oct 20, 2026TrialEffects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer

Oct 17, 2026TrialPrognostic and Predictive Value of Tumor Molecular Alterations in Patients With Prostate Cancer

Oct 17, 2026TrialOsimertinib as First Line Therapy for Patients With Advanced EGFR Positive Non-Small Cell Lung Cancer: the Experience of the Hellenic Cooperative Oncology Group (HeCOG)

4 more events

Oct 17, 2026TrialDetection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer

Oct 16, 2026TrialDurvalumab in Combination With Standard Chemotherapy for 1st Line Therapy of Patients With Extensive Stage Small Cell Lung Cancer: A Non-interventional, Prospective Observational Study of Clinical Practice, Quality of Life and Use of Health Resources in Real-world Clinical Practice (DRIVE)